Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Politics1 min read

LIVE Today: PSA's Friday News Roundup

Streaming Live via PSA and our friends at Psychedelics Today

By Jack Gorsline

Contributor ·

LIVE Today: PSA's Friday News Roundup

Psychedelic State(s) of America’s Friday News Roundup

March 6th, 2025

Tune in LIVE today at 2:00 PM eastern / 11:00 AM pacific via Psychedelic State(s) of America and Psychedelics Today Via Youtube, LinkedIn, Facebook, Twitter/X, and more!


Hosted by PSA Founder and Investigative Journalist Jack Gorsline, this week’s Friday News Roundup features:

  • State-level psychedelic updates in Connecticut, Hawaii, Virginia, Georgia and beyond!
  • How this week’s Congressional Primary election results in Texas might impact Federal psychedelic policy reform efforts
  • Why hasn’t the private “big pharma” partner for the Texas Ibogaine Research Consortium been announced yet?

You won’t want to miss this!

Support independent journalism

The PSA Media Fund

Psychedelic State(s) of America isn’t another news outlet — it’s a vessel to help the fantastic independent psychedelic and cannabis media organizations that already exist do more of what they do best. Our coverage is reader-funded, and your support keeps news, commentary, and education on psychedelic policy free for everyone.

Donate to PSA

Until next time,
The Psychedelic State(s) of America Team

Read our Editorial StandardsRequest a correction

You read to the end

Get PSA News & Investigations in your inbox

Free to read. Free to subscribe.

About the author

Jack Gorsline

Contributor

Jack Gorsline is a Washington, D.C.-based investigative reporter covering the politics of drug policy reform - with a focus on psychedelics and cannabis legalization advocacy both in the United States and around the world. Jack’s reporting has been published by the Boston Institute for Nonprofit Journalism (BINJ), Talking Joints Memo, DoubleBlind Magazine, Filter Magazine, Marijuana Moment, Psychedelic Alpha, Lucid News, Cannabis & Tech Today, Reality Sandwich, High Times Magazine, and featured by Psychedelics Today, Ecstatic Integration, and The Mycopreneur Podcast, GBH Radio, The Microdose from UC’s Berkeley Center for the Science of Psychedelics, among others. Jack is also the founder of both Psychedelic State(s) of America and The Psychedelic Writers Guild (PWG) - a new nonprofit sponsored community building-oriented, collaborative media project being created in partnership with a diverse coalition of psychedelic scientists, journalists, medical practitioners, legal professionals, political advocates, and community leaders from around the world. You can find Jack on Twitter @JackGorsline, Instagram @Jack.Gorsline, Linkedin, Substack, Bluesky, and more!

Related stories

Picked by shared tags, desk, and byline.